Pasar al contenido principal

Efecto de los factores de estilo de vida en la composición corporal (subestudio DXA de PREDIMED+DM)

IJC2019-042420-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Juan de la Cierva Incorporación
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓ INSTITUT D'INVESTIGACIÓ SANITÀRIA ILLES BALEARS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Estimated phytate intake is associated with bone mineral density in mediterranean postmenopausal women

  • Sanchís, Pilar
  • Prieto, Rafael M.
  • Konieczna, Jadwiga
  • Grases, Félix
  • Abete, Itziar
  • Salas Salvadó, Jordi
  • Martín, Vicente
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • García-Gavilán, Jesús Francisco
  • Goday Arnó, Albert
  • Costa-Bauza, Antonia
  • Martínez, José Alfredo
  • Romaguera Bosch, Dora
The main objective of this work was to explore the association of dietary phytate intake with bone mineral density (BMD) in a Mediterranean population of postmenopausal women. For this purpose, a cross-sectional analysis of 561 women aged 55-75 years with overweight/obesity and metabolic syndrome from a Mediterranean area and with data on dual-energy X-ray absorptiometry (DXA) scans in femur and lumbar spine was performed. Estimated phytate intake was calculated using a validated food frequency questionnaire. Our results indicated that phytate intake was associated with BMD [β(95%CI) per each 25 mg/100 kcal] in femoral neck [0.023(0.060-0.040) g/cm2], femoral Ward's triangle [0.033(0.013-0.054) g/cm2], total femur [0.018(0.001-0.035) g/cm2], and all the analyzed lumbar spine sites [L1-L4: 0.033(0.007-0.059) g/cm2] after adjusting for potential confounders. The sensitivity analysis showed that phytate intake was directly associated with lumbar spine BMD in women younger than 66 years, with a body mass index higher than 32.6 kg/cm2 and without type 2 diabetes (all p-for interactions < 0.05). The overall results indicated that phytate, a substance present in food as cereals, legumes and nuts, was positively associated with BMD in Mediterranean postmenopausal women. Phytate may have a protective effect on bone resorption by adsorbing on the surfaces of HAP. Nevertheless, large, long-term, and randomized prospective clinical studies must be performed to assess the possible benefits of phytate consumption on BMD in postmenopausal women., This research was funded by the ‘National Institutes of Health’ [NIH 1R01DK127601] granted to MR-C and JS-S; ‘European Research Council’ [Advanced Research Grant 2014–2019; agreement #340918] granted to MÁM-G; and the ‘Spanish National Health Institute of Health Carlos III (ISCIII)’, through ‘CIBEROBN’ and ‘Fondo de Investigación para la Salud’ (FIS), which is co-funded by the ‘European Regional Development Fund’ [PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462,PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722,PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919,PI14/00853,PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662,PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366,PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508,PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032,PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158, PI20/0471]; the ‘Especial Action Project’ entitled: Implementación y evaluación de una intervención intensive sobre la actividad física Cohorte PREDIMEDPlus grant to JS-S; the ‘Recercaixa’ [number 2013ACUP00194] grant to JS-S; grants from the ‘Consejería de Salud de la Junta de Andalucía’ (PI0458/2013, PS0358/2016,PI0137/2018); the [PROMETEO/2017/017] grant from the ‘Generalitat Valenciana’; the SEMERGEN grant. Juan de la Cierva-Incorporación research grant [IJC2019-042420-I] of the ‘Spanish Ministry of Economy, Industry and Competitiveness’ and ‘European Social Funds’ to JK. This work was also partially supported by ‘ICREA’ under the ICREA Academia programme. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat

  • Henn, Mathias
  • Fitó Colomer, Montserrat
  • Schröder, Helmut
  • Ruiz-Canela, Miguel
Background & aims Higher consumption of coffee and caffeine has been linked to less weight gain and lower body mass index in prospective cohort studies. The aim of the study was to longitudinally assess the association of changes in coffee and caffeine intake with changes in fat tissue, in particular, visceral adipose tissue (VAT) using dual x-ray absorptiometry (DXA). Methods In the setting of a large, randomized trial of Mediterranean diet and physical activity intervention, we evaluated 1483 participants with metabolic syndrome (MetS). Repeated measurements of coffee consumption from validated food frequency questionnaires (FFQ) and DXA measurements of adipose tissue were collected at baseline, 6 months, 12 months and 3 years of follow-up. DXA-derived measurements of total and regional adipose tissue expressed as % of total body weight were transformed into sex-specific z-scores. Linear multilevel mixed-effect models were used to investigate the relationship between changes in coffee consumption and corresponding concurrent changes in fat tissue during a 3-year follow-up. Results After adjustment for intervention group, and other potential confounders, an increase in caffeinated coffee consumption from no or infrequent consumption (≤3 cups/month) to moderate consumption (1–7 cups/week) was associated with reductions in total body fat (Δ z-score: −0.06; 95% CI: −0.11 to −0.02), trunk fat (Δ z-score: −0.07; 95% CI: −0.12 to −0.02), and VAT (Δ z-score: −0.07; 95% CI: −0.13 to −0.01). Neither changes from no or infrequent consumption to high levels of caffeinated coffee consumption (>1 cup/day) nor any changes in decaffeinated coffee consumption showed significant associations with changes in DXA measures. Conclusions Moderate changes in the consumption of caffeinated coffee, but not changes to high consumption, were associated with reductions in total body fat, trunk fat and VAT in a Mediterranean cohort with MetS. Decaffeinated coffee was not linked to adiposity indicators. Moderate consumption of caffeinated coffee may be part of a weight management strategy., The PREDIMED-Plus trial was supported by the official funding agency for biomedical research of the Spanish Government, Instituto de Salud Carlos III ([Carlos III Health Institute], Sevilla, Spain), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/0147, PI14/00636, PI14/00972, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158, the European Research Council Advanced Research Grant 2013–2018 340918, the Recercaixa grant 2013ACUP00194, grants from the Consejería de Salud de la Junta de Andalucía PI0458/2013; PS0358/2016, PI0137/2018, the PROMETEO/2017/017 grant from the Generalitat Valenciana, the SEMERGEN grant, FEDER funds CB06/03 and the NIH grant 1R01DK127601-01. Dr. Salas-Salvadó is partially supported by ICREA under the ICREA Academia Program. JK is supported by Juan de la Cierva-Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds. None of the funding sources took part in the design, collection, analysis or interpretation of the data and in writing the manuscript, or in the decision to submit the manuscript for publication.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study

  • Nishi, Stephanie
  • Fitó Colomer, Montserrat
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Water intake and hydration status have been suggested to impact cognition; however, longitudinal evidence is limited and often inconsistent. This study aimed to longitudinally assess the association between hydration status and water intake based on current recommendations, with changes in cognition in an older Spanish population at high cardiovascular disease risk. Methods A prospective analysis was conducted of a cohort of 1957 adults (aged 55–75) with overweight/obesity (BMI between ≥ 27 and < 40 kg/m2) and metabolic syndrome from the PREDIMED-Plus study. Participants had completed bloodwork and validated, semiquantitative beverage and food frequency questionnaires at baseline, as well as an extensive neuropsychological battery of 8 validated tests at baseline and 2 years of follow-up. Hydration status was determined by serum osmolarity calculation and categorized as < 295 mmol/L (hydrated), 295–299.9 mmol/L (impending dehydration), and ≥ 300 mmol/L (dehydrated). Water intake was assessed as total drinking water intake and total water intake from food and beverages and according to EFSA recommendations. Global cognitive function was determined as a composite z-score summarizing individual participant results from all neuropsychological tests. Multivariable linear regression models were fitted to assess the associations between baseline hydration status and fluid intake, continuously and categorically, with 2-year changes in cognitive performance. Results The mean baseline daily total water intake was 2871 ± 676 mL/day (2889 ± 677 mL/day in men; 2854 ± 674 mL/day in women), and 80.2% of participants met the ESFA reference values for an adequate intake. Serum osmolarity (mean 298 ± 24 mmol/L, range 263 to 347 mmol/L) indicated that 56% of participants were physiologically dehydrated. Lower physiological hydration status (i.e., greater serum osmolarity) was associated with a greater decline in global cognitive function z-score over a 2-year period (β: − 0.010; 95% CI − 0.017 to − 0.004, p-value = 0.002). No significant associations were observed between water intake from beverages and/or foods with 2-year changes in global cognitive function. Conclusions Reduced physiological hydration status was associated with greater reductions in global cognitive function over a 2-year period in older adults with metabolic syndrome and overweight or obesity. Future research assessing the impact of hydration on cognitive performance over a longer duration is needed. Trial registration International Standard Randomized Controlled Trial Registry, ISRCTN89898870. Retrospectively registered on 24 July 2014, This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO 17/2017 and PROMETEO 21/2021 grant from the Generalitat Valenciana; the SEMERGEN grant; and the Juan de la Cierva-Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2) and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). S.K.N. is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). CG-M is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). IP-G is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). AA-S has received a post-doctoral grant (APOSTD/2020/164) from the Consellería de Innovación, Ciencia y Sociedad Digital, Generalitat Valenciana, Fondo Social Europeo-FSE. CB is supported by a Juan de la Cierva postdoctoral grant from Ministerio de Ciencia, Innovación y Universidades. JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program. Publication of this work is supported by a conference award grant from Hydration for Health presented by the Danone Global Research & Innovation Center (#2022-08514) awarded to S.K.N. for being the conference attendee voted recipient of the Early Career Researcher Award. None of the funding sources took part in the design, collection, analysis, interpretation of the data; writing of the report; or the decision to submit the manuscript for publication.
Repositori Institucional UIB
Publicación Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga
  • Fiol, Miguel
  • Colom, Antoni
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Soria-Florido, María Trinidad
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • López-Miranda, José
  • Estruch, Ramon
  • Bernal-López, M. Rosa
  • Lapetra, José
  • Serra-Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Bes-Rastrollo, Maira
  • Pascual, María
  • Sorlí, Jose V.
  • Goday, Albert
  • Zulet, María Ángeles
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • Garcia-Rios, Antonio
  • Casas, Rosa
  • Gómez-Pérez, Ana M.
  • Santos-Lozano, José Manuel
  • Basterra-Gortari, F. Javier
  • Martínez, María Ángeles
  • Ortega-Azorin, Carolina
  • Bayó, Joan
  • Abete, Itziar
  • Salaverria-Lete, Itziar
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • Carres, Lourdes
  • Romaguera, Dora
[eng] Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p-values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS,
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat

  • Henn, Mathias
  • Fitó Colomer, Montserrat
  • Schröder, Helmut
  • Ruiz-Canela, Miguel
Background & aims Higher consumption of coffee and caffeine has been linked to less weight gain and lower body mass index in prospective cohort studies. The aim of the study was to longitudinally assess the association of changes in coffee and caffeine intake with changes in fat tissue, in particular, visceral adipose tissue (VAT) using dual x-ray absorptiometry (DXA). Methods In the setting of a large, randomized trial of Mediterranean diet and physical activity intervention, we evaluated 1483 participants with metabolic syndrome (MetS). Repeated measurements of coffee consumption from validated food frequency questionnaires (FFQ) and DXA measurements of adipose tissue were collected at baseline, 6 months, 12 months and 3 years of follow-up. DXA-derived measurements of total and regional adipose tissue expressed as % of total body weight were transformed into sex-specific z-scores. Linear multilevel mixed-effect models were used to investigate the relationship between changes in coffee consumption and corresponding concurrent changes in fat tissue during a 3-year follow-up. Results After adjustment for intervention group, and other potential confounders, an increase in caffeinated coffee consumption from no or infrequent consumption (≤3 cups/month) to moderate consumption (1–7 cups/week) was associated with reductions in total body fat (Δ z-score: −0.06; 95% CI: −0.11 to −0.02), trunk fat (Δ z-score: −0.07; 95% CI: −0.12 to −0.02), and VAT (Δ z-score: −0.07; 95% CI: −0.13 to −0.01). Neither changes from no or infrequent consumption to high levels of caffeinated coffee consumption (>1 cup/day) nor any changes in decaffeinated coffee consumption showed significant associations with changes in DXA measures. Conclusions Moderate changes in the consumption of caffeinated coffee, but not changes to high consumption, were associated with reductions in total body fat, trunk fat and VAT in a Mediterranean cohort with MetS. Decaffeinated coffee was not linked to adiposity indicators. Moderate consumption of caffeinated coffee may be part of a weight management strategy., The PREDIMED-Plus trial was supported by the official funding agency for biomedical research of the Spanish Government, Instituto de Salud Carlos III ([Carlos III Health Institute], Sevilla, Spain), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/0147, PI14/00636, PI14/00972, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158, the European Research Council Advanced Research Grant 2013–2018 340918, the Recercaixa grant 2013ACUP00194, grants from the Consejería de Salud de la Junta de Andalucía PI0458/2013; PS0358/2016, PI0137/2018, the PROMETEO/2017/017 grant from the Generalitat Valenciana, the SEMERGEN grant, FEDER funds CB06/03 and the NIH grant 1R01DK127601-01. Dr. Salas-Salvadó is partially supported by ICREA under the ICREA Academia Program. JK is supported by Juan de la Cierva-Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds. None of the funding sources took part in the design, collection, analysis or interpretation of the data and in writing the manuscript, or in the decision to submit the manuscript for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study

  • Nishi, Stephanie
  • Fitó Colomer, Montserrat
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Water intake and hydration status have been suggested to impact cognition; however, longitudinal evidence is limited and often inconsistent. This study aimed to longitudinally assess the association between hydration status and water intake based on current recommendations, with changes in cognition in an older Spanish population at high cardiovascular disease risk. Methods A prospective analysis was conducted of a cohort of 1957 adults (aged 55–75) with overweight/obesity (BMI between ≥ 27 and < 40 kg/m2) and metabolic syndrome from the PREDIMED-Plus study. Participants had completed bloodwork and validated, semiquantitative beverage and food frequency questionnaires at baseline, as well as an extensive neuropsychological battery of 8 validated tests at baseline and 2 years of follow-up. Hydration status was determined by serum osmolarity calculation and categorized as < 295 mmol/L (hydrated), 295–299.9 mmol/L (impending dehydration), and ≥ 300 mmol/L (dehydrated). Water intake was assessed as total drinking water intake and total water intake from food and beverages and according to EFSA recommendations. Global cognitive function was determined as a composite z-score summarizing individual participant results from all neuropsychological tests. Multivariable linear regression models were fitted to assess the associations between baseline hydration status and fluid intake, continuously and categorically, with 2-year changes in cognitive performance. Results The mean baseline daily total water intake was 2871 ± 676 mL/day (2889 ± 677 mL/day in men; 2854 ± 674 mL/day in women), and 80.2% of participants met the ESFA reference values for an adequate intake. Serum osmolarity (mean 298 ± 24 mmol/L, range 263 to 347 mmol/L) indicated that 56% of participants were physiologically dehydrated. Lower physiological hydration status (i.e., greater serum osmolarity) was associated with a greater decline in global cognitive function z-score over a 2-year period (β: − 0.010; 95% CI − 0.017 to − 0.004, p-value = 0.002). No significant associations were observed between water intake from beverages and/or foods with 2-year changes in global cognitive function. Conclusions Reduced physiological hydration status was associated with greater reductions in global cognitive function over a 2-year period in older adults with metabolic syndrome and overweight or obesity. Future research assessing the impact of hydration on cognitive performance over a longer duration is needed. Trial registration International Standard Randomized Controlled Trial Registry, ISRCTN89898870. Retrospectively registered on 24 July 2014, This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO 17/2017 and PROMETEO 21/2021 grant from the Generalitat Valenciana; the SEMERGEN grant; and the Juan de la Cierva-Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2) and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). S.K.N. is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). CG-M is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). IP-G is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). AA-S has received a post-doctoral grant (APOSTD/2020/164) from the Consellería de Innovación, Ciencia y Sociedad Digital, Generalitat Valenciana, Fondo Social Europeo-FSE. CB is supported by a Juan de la Cierva postdoctoral grant from Ministerio de Ciencia, Innovación y Universidades. JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program. Publication of this work is supported by a conference award grant from Hydration for Health presented by the Danone Global Research & Innovation Center (#2022-08514) awarded to S.K.N. for being the conference attendee voted recipient of the Early Career Researcher Award. None of the funding sources took part in the design, collection, analysis, interpretation of the data; writing of the report; or the decision to submit the manuscript for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Estimated phytate intake is associated with bone mineral density in mediterranean postmenopausal women

  • Sanchís, Pilar
  • Prieto, Rafael M.
  • Konieczna, Jadwiga
  • Grases, Félix
  • Abete, Itziar
  • Salas Salvadó, Jordi
  • Martín, Vicente
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • García-Gavilán, Jesús Francisco
  • Goday Arnó, Albert
  • Costa-Bauza, Antonia
  • Martínez, José Alfredo
  • Romaguera Bosch, Dora
The main objective of this work was to explore the association of dietary phytate intake with bone mineral density (BMD) in a Mediterranean population of postmenopausal women. For this purpose, a cross-sectional analysis of 561 women aged 55-75 years with overweight/obesity and metabolic syndrome from a Mediterranean area and with data on dual-energy X-ray absorptiometry (DXA) scans in femur and lumbar spine was performed. Estimated phytate intake was calculated using a validated food frequency questionnaire. Our results indicated that phytate intake was associated with BMD [β(95%CI) per each 25 mg/100 kcal] in femoral neck [0.023(0.060-0.040) g/cm2], femoral Ward's triangle [0.033(0.013-0.054) g/cm2], total femur [0.018(0.001-0.035) g/cm2], and all the analyzed lumbar spine sites [L1-L4: 0.033(0.007-0.059) g/cm2] after adjusting for potential confounders. The sensitivity analysis showed that phytate intake was directly associated with lumbar spine BMD in women younger than 66 years, with a body mass index higher than 32.6 kg/cm2 and without type 2 diabetes (all p-for interactions < 0.05). The overall results indicated that phytate, a substance present in food as cereals, legumes and nuts, was positively associated with BMD in Mediterranean postmenopausal women. Phytate may have a protective effect on bone resorption by adsorbing on the surfaces of HAP. Nevertheless, large, long-term, and randomized prospective clinical studies must be performed to assess the possible benefits of phytate consumption on BMD in postmenopausal women., This research was funded by the ‘National Institutes of Health’ [NIH 1R01DK127601] granted to MR-C and JS-S; ‘European Research Council’ [Advanced Research Grant 2014–2019; agreement #340918] granted to MÁM-G; and the ‘Spanish National Health Institute of Health Carlos III (ISCIII)’, through ‘CIBEROBN’ and ‘Fondo de Investigación para la Salud’ (FIS), which is co-funded by the ‘European Regional Development Fund’ [PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462,PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722,PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919,PI14/00853,PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662,PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366,PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508,PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032,PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158, PI20/0471]; the ‘Especial Action Project’ entitled: Implementación y evaluación de una intervención intensive sobre la actividad física Cohorte PREDIMEDPlus grant to JS-S; the ‘Recercaixa’ [number 2013ACUP00194] grant to JS-S; grants from the ‘Consejería de Salud de la Junta de Andalucía’ (PI0458/2013, PS0358/2016,PI0137/2018); the [PROMETEO/2017/017] grant from the ‘Generalitat Valenciana’; the SEMERGEN grant. Juan de la Cierva-Incorporación research grant [IJC2019-042420-I] of the ‘Spanish Ministry of Economy, Industry and Competitiveness’ and ‘European Social Funds’ to JK. This work was also partially supported by ‘ICREA’ under the ICREA Academia programme. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Fiol-Sala, Miquel
  • Colom, Antoni|||0000-0001-5041-0778
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Soria-Florido, María Trinidad|||0000-0002-5625-9033
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Pascual, María
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez Pérez, Ana María|||0000-0002-2874-5894
  • Santos-Lozano, José Manuel
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Martínez, María Ángeles
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Bayó, Joan
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Carres, Lourdes
  • Romaguera, Dora|||0000-0002-5762-8558
Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p -values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Dairy product consumption and changes in cognitive performance: two-year analysis of the PREDIMED-Plus Cohort

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Gómez-Gracia, Enrique
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Lluis
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín-Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Barabash Bustelo, Ana
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Coltell, Oscar
  • Gómez-Martínez, Carlos
  • Zomeño, María Dolores
  • Donat Vargas, Carolina
  • Goicolea-Güemez, Leire
  • Bouzas, Cristina
  • García de la Hera, Manuela
  • Chaplin, Alice
  • García-Ríos, Antonio
  • Casas, Rosa
  • Cornejo-Pareja, Isabel
  • Santos Lozano, José Manuel
  • Rognoni, Teresa
  • Saiz, Carmen
  • Paz-Graniel, Indira
  • Malcampo, Mireia
  • Sánchez Villegas, María Almudena
  • Salaverria-Lete, Itziar
  • García-Arellano, Ana
  • Schröder, Helmut
  • Salas-Salvadó, Jordi
Scope: Dairy consumption has been suggested to impact cognition; however, evidence is limited and inconsistent. This study aims to longitudinally assess the association between dairy consumption with cognitive changes in an older Spanish population at high cardiovascular disease risk. Methods and results: Four thousand six hundred sixty eight participants aged 55–75 years, completed a validated food frequency questionnaire at baseline and a neuropsychological battery of tests at baseline and 2-year follow-up. Multivariable linear regression models are used, scaled by 100 (i.e., the units of β correspond to 1 SD/100), to assess associations between baseline tertile daily consumption and 2-year changes in cognitive performance. Participants in the highest tertile of total milk and whole-fat milk consumption have a greater decline in global cognitive function (β: –4.71, 95% CI: –8.74 to –0.69, p-trend = 0.020 and β: –6.64, 95% CI: –10.81 to –2.47, p-trend = 0.002, respectively) compared to those in the lowest tertile. No associations are observed between low fat milk, yogurt, cheese or fermented dairy consumption, and changes in cognitive performance. Conclusion:Results suggest there are no clear prospective associations between consumption of most commonly consumed dairy products and cognition, although there may be an association with a greater rate of cognitive decline over a 2-year period in older adults at high cardiovascular disease risk for whole-fat milk., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six coordinated FIS projects leaded by J.S.-S. and J.Vi., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/ 02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/ 01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/ 00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/ 01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/ 00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S.; the European Research Council (Advanced Research Grant 2014– 2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO/2021/021 grants from the Generalitat Valenciana; the SEMERGEN grant; Juan de la Cierva–Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds to JK. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). J.N. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). C.G.-M. is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). I.P.-G. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). J.S.-S., senior author of this paper, was partially supported by ICREA under the ICREA Academia program.